Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil

Purpose: To compare treatment outcomes and adverse events between concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) and conventional concurrent chemoradiotherapy with cisplatin and 5-fluorouracil (CF-RT). Methods and Materials: We retrospectively investigated treatm...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Cancer
Autori principali: Tamaki, Yukihisa, Hieda, Yoko, Nakajima, Masanobu, Kitajima, Kazuhiro, Yoshida, Rika, Yoshizako, Takeshi, Ue, Atsushi, Tokudo, Mutsumi, Hirahara, Noriyuki, Moriyama, Ichiro, Kato, Hiroyuki, Inomata, Taisuke
Natura: Artigo
Lingua:Inglês
Pubblicazione: Ivyspring International Publisher 2018
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6096357/
https://ncbi.nlm.nih.gov/pubmed/30123343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.23456
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi